No abstract available
Keywords:
Ayvakit; GIST; Gleevec; Qinlock; Stivarga; Sutent; adverse effects; avapritinib; dosage; drug interactions; efficacy; imatinib; lactation; pregnancy; regorafenib; ripretinib; safety; sunitinib.
MeSH terms
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use*
-
Gastrointestinal Neoplasms / drug therapy*
-
Gastrointestinal Neoplasms / enzymology
-
Gastrointestinal Neoplasms / mortality
-
Gastrointestinal Neoplasms / pathology
-
Gastrointestinal Stromal Tumors / drug therapy*
-
Gastrointestinal Stromal Tumors / enzymology
-
Gastrointestinal Stromal Tumors / mortality
-
Gastrointestinal Stromal Tumors / pathology
-
Humans
-
Molecular Targeted Therapy
-
Naphthyridines / adverse effects
-
Naphthyridines / therapeutic use*
-
Progression-Free Survival
-
Protein Kinase Inhibitors / adverse effects
-
Protein Kinase Inhibitors / therapeutic use*
-
Time Factors
-
Urea / adverse effects
-
Urea / analogs & derivatives*
-
Urea / therapeutic use
Substances
-
Antineoplastic Agents
-
Naphthyridines
-
Protein Kinase Inhibitors
-
Urea
-
ripretinib